|
|
Article: Dey Launches and Unveils Next-Generation, Needle-Protected EpiPen[R] (Epinephrine) Auto-Injector with Enhanced Patient-Friendly Features.
- Article from:
- Biotech Week
- Article date:
- November 11, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Dey Pharma, L.P., a subsidiary of Mylan Inc. (NASDAQ:MYL), today launched a newly designed, patient-friendly EpiPen=AE Auto-Injector 0.3/0.15 mg. This next-generation EpiPen Auto-Injector maintains the simplicity, speed, safety and reliability of EpiPen Auto-Injector with several new, user-friendly features, including being the only auto-injector with needle-protection before and after use (see also Anaphylactic Shock).
Dey President Carolyn Myers, Ph.D., said: "We are very pleased to be launching Dey's highly anticipated next-generation, needle-protected EpiPen Auto-Injector. The objective of the product's new features is to give those who carry an epinephrine ...